Court rules that e-cigarette retailers can seek judicial review in the 5th Circuit

The Supreme Court, in a 7-2 decision, ruled that retailers of R.J. Reynolds Vapor's e-cigarette products have the right to legally challenge the FDA's denial of the company's marketing application in the 5th Circuit Court of Appeals, where the retailers are based. The ruling allows retailers to seek judicial review under the Family Smoking Prevention and Tobacco Control Act if they are "adversely affected" by the FDA's decisions, which the court determined includes the loss of potential profit. This decision potentially opens the door for challenges to FDA rulings in circuits beyond those where the manufacturer is based, though a dissenting opinion suggests this effectively weakens the zone-of-interest test.

Analysis

The Supreme Court's 7-2 ruling represents a significant procedural victory for R.J. Reynolds Vapor (RJR), allowing a challenge to the FDA's marketing denial order for its e-cigarette products to proceed in the U.S. Court of Appeals for the 5th Circuit. This development is material because the 5th Circuit is perceived as a more favorable venue for RJR compared to the 4th Circuit, which has previously rejected similar e-cigarette challenges. The court's decision hinges on a broad interpretation of who is "adversely affected" under the Tobacco Control Act, now formally including retailers who stand to lose profits. This effectively provides a legal pathway for manufacturers to engage in "venue shopping" by joining lawsuits with retailers in preferred jurisdictions. While the Court did not rule on whether a manufacturer could file independently outside its home circuit, this decision establishes a clear precedent for challenging FDA rulings via retailer partnerships. The dissenting opinion highlights a potential long-term risk that this ruling could weaken the "zone-of-interest" test, broadening the scope for legal challenges against federal agencies across various industries.

Key Decisions for Investors

• This ruling is a moderately positive catalyst for R.J. Reynolds, as it reopens a legal avenue to potentially overturn the FDA's marketing denial for its vapor products, which could unlock a previously blocked revenue stream.
• Investors should monitor the subsequent proceedings in the 5th Circuit Court, as the Supreme Court's decision is purely procedural and does not guarantee a favorable outcome on the merits of the marketing application itself.
• The precedent set by this case could be advantageous for the broader tobacco and vaping industry, offering a new strategic playbook for challenging adverse FDA regulatory decisions by leveraging retailer lawsuits in more sympathetic legal circuits.